COMMUNIQUÉS West-GlobeNewswire

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 25 - 2024
25/06/2024
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 17 au 21 juin 2024 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Higher cantonal composition authority approved the amendments to the terms of the 2024 convertible bonds
25/06/2024
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – June 25, 2024 Idorsia Ltd (SIX: IDIA) today announced that the hearing by the higher cantonal composition authority ( obere kantonale Nachlassbehörde [...]
Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion
25/06/2024
Company announcement – No. 33 / 2024 Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN [...]
CORRECTION: Capricor Therapeutics
25/06/2024
SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) -- In a release issued under the headline "Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy" on Tuesday, June 25th by Capricor Therapeutics, [...]
Ursula Burns, former Xerox CEO, and Jordan Wertlieb, EVP and COO of Hearst, appointed to the Pediatric Brain Tumor Foundation’s Advisory Board as inaugural members
25/06/2024
Renowned business leaders Burns and Wertlieb to serve as special advisors to PBTF Board of Directors NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- The Pediatric Brain Tumor Foundation (PBTF) today announced the [...]
Pressure BioSciences Partners with Vita-Forte, Largest Global Supplier of Freeze-Dried Acai, to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray
25/06/2024
Processed by PBIO’s Patented UltraShear Technology, this Revolutionary Product Combines Leading Potency Oil-Based Antioxidants (e.g., Acai, Curcumin, Astaxanthin, CoQ10, & More) into a Super-Fast Absorbing, Highly [...]
BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial
25/06/2024
Through this partnership, BlueSphere will treat patients with acute myeloid and lymphocytic leukemia, and myeloid dysplastic syndrome, who have active disease or are at high risk for relapse, with the goal of reducing [...]
MEDIROM Healthcare Technologies Inc. Announces Financial Results for Fiscal Year 2023
25/06/2024
TOKYO, June 25, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”), a holistic healthcare company based in Japan, announced it filed its Annual Report on Form 20-F [...]
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
25/06/2024
HOUSTON, June 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of [...]
Cingulate Achieves Key Manufacturing Milestone in the Development of its ADHD Drug CTx-1301 in Preparation for FDA Marketing Clearance
25/06/2024
Twelve Required Registration Batches Completed New Drug Application Being Prepped for Submission KANSAS CITY, Kan., June 25, 2024 (GLOBE NEWSWIRE) -- In alignment with U.S. Food and Drug Administration (FDA) [...]
InkSpace Imaging Broadens Body Array Access Across GE HealthCare 3T MRI Systems
25/06/2024
PLEASANTON, Calif., June 25, 2024 (GLOBE NEWSWIRE) -- InkSpace Imaging proudly announces that GE Healthcare has certified their Snuggle™ and Silhouette™ MRI body arrays. They are now compatible with GE HealthCare Signa [...]
Samsung Bioepis Releases 2024 Sustainability Report, Highlighting Progress in Accessibility and R&D Innovation
25/06/2024
Report highlights key progress and achievements across three pillars: access to medicines, R&D innovation, and product quality and patient safety 430,000 patients have been treated with Samsung Bioepis’ biosimilars [...]
Shape Therapeutics Appoints Healthcare Industry Leaders David Epstein and Todd Simpson to its Board of Directors
25/06/2024
Epstein and Simpson bring significant life sciences industry expertise that will be integral to the Company’s continued growth as a leader in AI for genomic medicine SEATTLE, June 25, 2024 (GLOBE NEWSWIRE) -- Shape [...]
Privia Receives HFMA’s MAP Award for High Performance in Revenue Cycle for Performance Year 2023
25/06/2024
Privia Health has received the HFMA MAP Award in eight of the past nine years ARLINGTON, Va., June 25, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that its network of affiliated medical [...]
NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System
25/06/2024
Five ablations performed successfully in one patient Procedure performed at patient’s bedside saving time and cost associated with the operating room EDEN PRAIRIE, Minn., June 25, 2024 (GLOBE NEWSWIRE) -- NeuroOne [...]
T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
25/06/2024
LEXINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a [...]
Safety Shot Announces Strategic Partnership with Chip Quigley and Ari Freedman
25/06/2024
The Executives Will Support the Company with Deep Expertise Across Entertainment, Development and Distribution JUPITER, FL, June 25, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) proudly announces today a [...]
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.
25/06/2024
First Commercial Agreement for DispersinB® WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has entered into a worldwide [...]
Oragenics, Inc. Announces Pricing of Public Offering
25/06/2024
SARASOTA, Fla., June 25, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced [...]

Pages